To explore new therapeutic targets for AML, we conducted a transcriptome analysis on BMMNCs from five AML patients and granulocyte colony‐stimulating factor (G‐CSF)‐mobilized PBSCs from five healthy donors (NCBI database SRA accession: PRJNA576718). The gene discussed is CSF3; the disease is acute myeloid leukemia.